115 related articles for article (PubMed ID: 1323947)
21. Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions.
Cullen KJ; Smith HS; Hill S; Rosen N; Lippman ME
Cancer Res; 1991 Sep; 51(18):4978-85. PubMed ID: 1893385
[TBL] [Abstract][Full Text] [Related]
22. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
24. [Detection of tumor necrosis factor mRNA expression in human cervix and endometrium by in situ hybridization].
Ding SY; Wu R
Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):244-6. PubMed ID: 12390778
[TBL] [Abstract][Full Text] [Related]
25. Molecular genetic analysis of TGF-beta1 in ovarian neoplasia.
Cardillo MR; Yap E; Castagna G
J Exp Clin Cancer Res; 1997 Mar; 16(1):49-56. PubMed ID: 9148861
[TBL] [Abstract][Full Text] [Related]
26. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor. Expression in human vulvar neoplastic and nonneoplastic tissues.
Doldi N; Origoni M; Bassan M; Ferrari D; Rossi M; Ferrari A
J Reprod Med; 1996 Nov; 41(11):844-8. PubMed ID: 8951136
[TBL] [Abstract][Full Text] [Related]
28. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.
Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA
Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723
[TBL] [Abstract][Full Text] [Related]
29. Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix.
Comerci JT; Runowicz CD; Flanders KC; De Victoria C; Fields AL; Kadish AS; Goldberg GL
Cancer; 1996 Mar; 77(6):1107-14. PubMed ID: 8635131
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.
Fujiwara Y; Higuchi K; Hamaguchi M; Takashima T; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Arakawa T
J Gastroenterol Hepatol; 2004 May; 19(5):521-7. PubMed ID: 15086595
[TBL] [Abstract][Full Text] [Related]
31. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
[TBL] [Abstract][Full Text] [Related]
33. Expression of transforming growth factor-alpha in the normal cervix and in benign and malignant lesions of the uterine cervix.
Konishi I; Ishikawa Y; Wang SY; Wang DP; Koshiyama M; Mandai M; Komatsu T; Yamamoto S; Mori T
Br J Obstet Gynaecol; 1994 Apr; 101(4):325-9. PubMed ID: 8199079
[TBL] [Abstract][Full Text] [Related]
34. [mRNA expression and protein localization of placental tissue protein 11, 12, 19 in gynecologic malignant tumors].
Yudate T; Isaka K; Suzuki Y; Takada J; Hosaka M; Shiraishi K; Nohira T; Shimizu R; Takayama M
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Nov; 47(11):1248-54. PubMed ID: 8543850
[TBL] [Abstract][Full Text] [Related]
35. Cervical squamous cell carcinoma in situ with intraepithelial extension to the upper genital tract and invasion of tubes and ovaries: report of a case with human papilloma virus analysis.
Pins MR; Young RH; Crum CP; Leach IH; Scully RE
Int J Gynecol Pathol; 1997 Jul; 16(3):272-8. PubMed ID: 9421094
[TBL] [Abstract][Full Text] [Related]
36. Thyroid transcription factor-1 expression in normal gynecologic tissues and its potential significance.
Niu HL; Pasha TL; Pawel BR; LiVolsi VA; Zhang PJ
Int J Gynecol Pathol; 2009 Jul; 28(4):301-7. PubMed ID: 19483637
[TBL] [Abstract][Full Text] [Related]
37. Assessment of EGFR and TGF-alpha expression in relationship to HPV status and Ki-67 distribution in cervical intraepithelial neoplasms.
Dellas A; Schultheiss E; Almendral AC; Torhorst J; Gudat F
Int J Cancer; 1996 Jun; 69(3):165-9. PubMed ID: 8682581
[TBL] [Abstract][Full Text] [Related]
38. Expression of midkine in benign, premalignant and malignant vulvar tumors.
Wu X; Yao J; Li Q; Zheng H; Xin Y
Chin Med Sci J; 2002 Sep; 17(3):148-52. PubMed ID: 12901536
[TBL] [Abstract][Full Text] [Related]
39. Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions.
Khorram O; Garthwaite M; Grosen E; Golos T
Fertil Steril; 2001 Jan; 75(1):174-9. PubMed ID: 11163834
[TBL] [Abstract][Full Text] [Related]
40. Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors.
Farré X; Guillén-Gómez E; Sánchez L; Hardisson D; Plaza Y; Lloberas J; Casado FJ; Palacios J; Pastor-Anglada M
Int J Cancer; 2004 Dec; 112(6):959-66. PubMed ID: 15386342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
